The University of Chicago Header Logo

Connection

Olatoyosi Odenike to CD47 Antigen

Back to Details
This is a "connection" page, showing publications Olatoyosi Odenike has written about CD47 Antigen.
Olatoyosi Odenike
Connection Strength
0.233
CD47 Antigen
  1. Treatment outcomes of venetoclax-combination regimens for relapsed/refractory myeloid malignancies after anti-CD47-directed therapy. Leuk Lymphoma. 2024 Jun; 65(6):864-867.
    View in: PubMed
    Score: 0.233
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.